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Abstract
Background: Over-expressed native or recombinant proteins are commonly used for industrial and pharmaceutical
purposes, as well as for research. Proteins of interest need to be purified in sufficient quantity, quality and specific
activity to justify their commercial price and eventual medical use. Proteome quality was previously positively
correlated with ribosomal fidelity, but not on a single protein level. Here, we show that decreasing translational
error rate increases the activity of single proteins. In order to decrease the amount of enzyme needed for catalysis,
we propose an expression system bearing rpsL141 mutation, which confers high ribosomal fidelity. Using alpha-
glucosidase (exo-alpha-1,4-glucosidase) and beta-glucanase (beta-D-glucanase) as examples, we show that proteins
purified from Escherichia coli bearing rpsL141 mutation have superior activity compared to those purified from wild
type E. coli, as well as some commercially available industrial enzymes.
Results: Our results indicate that both alpha-glucosidase and beta-glucanase isolated from E. coli bearing rpsL141
mutation have increased activity compared to those isolated from wild type E. coli. Alpha-glucosidase from rpsL141
background has a higher activity than the purchased enzymes, while beta-glucanase from the same background
has a higher activity compared to the beta-glucanase purchased from Sigma, but not compared to the one
purchased from Megazyme.
Conclusion: Reduction of the error rate in protein biosynthesis via ribosomal rpsL141 mutation results in superior
functionality of single proteins. We conclude that this is a viable system for expressing proteins with higher activity
and that it can be easily scaled up and combined with other expression systems to meet the industrial needs.
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Background
Proteins produced in and isolated from various microor-
ganisms are commonly used for vaccines and other
therapeutic purposes, as well as diagnostics, industrial
and research purposes. These proteins need to be puri-
fied in sufficient quantity and high quality. Thus, we
need near perfect proteins, whereas evolution selects ef-
ficacy rather than perfection as demonstrated by the
ease of selection for high fidelity protein biosynthesis in
bacteria, e.g., by streptomycin resistance. Therefore, pro-
teins produced by living cells are far from perfect already
during their biosynthesis and folding, and post-
synthetically during their intracellular and extracellular
maintenance. For instance, we have observed that the
proteome of Deinococcus radiodurans is five times less
oxidized in vivo than the Escherichia coli proteome [1].
As the world market for enzymes grows; in 2003 it was
estimated at $2.3 billion, and was expected to reach
$3.74 billion in 2015 [2, 3], it is important to improve
the quality of proteins, in particular therapeutic, and to
achieve cost effectiveness of production. This can be
done either by optimizing the purification processes, or
by optimizing the microorganisms used to overexpress
the protein. For example, lowering the growth
temperature and the medium pH can help correct fold-
ing and improve the activity of alpha-glucosidase
expressed in E. coli [4]. Overexpressing various protein
chaperons in E. coli (GroEL/GroES, DnaK/DnaJ/GrpE,
ClpB and the small HSPs lbpA/IbpB), alongside desired
protein overexpression, has been shown to increase the
yield of soluble protein [5]. This approach, however, may
impose additional stress on the cell, as it involves over-
expressing multiple proteins. An alternative to
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overexpressing chaperones would be to minimize the
need for them by optimizing the translation process, and
thus curtailing misfolding.
The prevailing source of protein damage in living cells
is oxidative damage. Two main sources of protein oxida-
tion in living cells are reactive oxygen species (ROS) and
the intrinsic susceptibility of proteins to oxidative dam-
age. A correlation has been shown between the synthesis
of aberrant proteins and their irreversible oxidation (car-
bonylation), as a result of their increased susceptibility
to damage [6]. Analogously, decreasing the error rate
during translation via ribosomal mutations reduces pro-
tein carbonylation at constant ROS levels [7]. Decreased
error rate during translation can be achieved by introdu-
cing the rpsL141 mutation, which carries an Asn for Lys
substitution at position 42 of S12 protein of the small
ribosomal subunit. rpsL141 affects the proofreading step
in translation i.e. increases the rejection rate of near-
cognate tRNAs, thus decreasing amino acid misincor-
poration [8]. Protein carbonylation level has already
been correlated with decreased cellular biosynthetic cap-
acity by Krisko and Radman [7] who showed that both
rpsL141 mutation and chaperone overexpressions
(GroEL/ES, Tig, DnaK) increase the single burst size of
λ phage in E. coli, reflecting increased functionality of
the cellular biosynthetic machinery.
As new genes are expressed and screened for protein
activity, in order to make their production financially vi-
able, the ability to express proteins in sufficient amount
and quality at a reasonable cost becomes a priority [2].
Since it meets the affordability criteria and is easily ma-
nipulated and grown on large scale, E. coli is the most
widely used prokaryotic system for the synthesis of
heterologous proteins, including alpha-glucosidase and
beta-glucanase [4, 5, 9–11]. We reasoned that reducing
the error rate during translation via rpsL141 mutation,
thus reducing proteome susceptibility to oxidative modi-
fication, would not only be beneficial for the entire prote-
ome, but would directly and indirectly improve the quality
of individual proteins and improve their specific activity.
By expressing alpha-glucosidase and beta-glucanase in
E. coli bearing the rpsL141 mutation, we show that it is
possible to achieve higher enzyme activity compared to
those expressed in the WT background. The advantage
of rpsL141 over chaperone overexpression is that it is a
genomic mutation and poses no additional stress, or
burden of plasmid maintenance, for the cell. We have,
thus, succeeded in reducing the amount of enzyme re-
quired to carry out a specific reaction. We believe that
this approach can be used for a wide variety of enzymes,
as well as in other expression systems, to reduce the
amount of enzyme needed for a reaction by improving
its activity and additionally, for therapeutic proteins, to
reduce their immunogenicity.
Methods
Gene encoding alpha-glucosidase from Bacillus stear-
othermophilus (pD441_BsAglu) and beta-glucanase from
Aspergillus niger (pD441_AnBglu) were synthesized and
cloned into a pD441 expression vector with a 1 × FLAG
peptide at the 3′ end (purchased from DNA 2.0). The
constructs were transformed into E. coli MG1655 and E.
coli rpsL141.
Protein extracts were obtained from 1 L of culture,
which was prepared by diluting overnight culture 200x
in LB with kanamycin and 100 μM isopropyl β-D-1-thio-
galactopyranoside (IPTG) and grown to saturation. Cells
were harvested by centrifugation and washed with
10 mM PBS, pH 7.4, and the pellet was lysed with 1 mg/
mL lysozyme in PBS supplied with protease inhibitor
cocktail (Thermo Scientific), at 37 °C for 60 min and cell
debris removed by a 20-min centrifugation at 10,000 × g.
The remaining supernatant was mixed with Anti-FLAG
Agarose Affinity Gel (Sigma), following manufacturer in-
structions. Cell lysates were incubated with the resin
overnight at 4 °C with shaking. Elution was performed
with 3 M MgCl2 for 30 to 60 min at 4 °C. Eluted protein
extract was then concentrated and the buffer was chan-
ged to PBS using Amicon centricons with 3 kDa cutoff.
Protein concentration was determined using BCA
(Pierce) and the product was checked by SDS-PAGE.
Purity of extracts was determined using SDS-Page and
ImageJ software by plotting each lane on a surface plot
and comparing the relative densities of the peaks. Yields
were expressed as total protein amount in mg obtained
after purification.
For comparison with proteins purified from E. coli
MG1655 and its congenic rpsL141 derivative, alpha-
glucosidase and beta-glucanase were purchased from
Megazyme and Sigma.
Megazyme alpha-glucosidase (E-TSAG) was supplied
as an ammonium sulfate suspension, and the buffer was
changed to PBS prior to activity measurements using
Centricon Centrifugal Units with a 3 kDa cutoff (Ami-
con). Megazyme beta-glucanase (E-CELAN) was sup-
plied as crystalline enzyme in ammonium sulphate and
was reconstituted in PBS prior to activity measurements.
Sigma alpha-glucosidase (G3651) was supplied as ly-
ophilized powder and was reconstituted in PBS prior to
activity measurement. Sigma beta-glucanase (49101) was
supplied as powder and was reconstituted in PBS prior
to activity measurement. Freeze-thaw cycles were mini-
mized by preparing fresh solutions.
The activity of exo-alpha-1,4-glucosidase enzymes pro-
duced in the two E. coli systems described above was
compared to the activity of exo-alpha-1,4-glucosidase
purchased from Megazyme (E-TSAGS) and Sigma
(G3651). All proteins were transferred into 10 mM PBS
pH 7.4 using Centricon Centrifugal Units with a 3 kDa
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cutoff (Amicon). The concentration of each enzyme
was adjusted to 0.5 mg/mL and the activity was mea-
sured using the Abnova Alpha-glucosidase Assay kit
(KA1608). Briefly, alpha-glucosidase hydrolyzes the ter-
minal, non-reducing 1,4-linked alpha-D-glucose resi-
dues with release of alpha-D-glucose. The method
utilizes p-nitrophenyl-α-D-glucopyranoside that is hy-
drolyzed specifically by alpha-glucosidase into a yellow
colored product (maximal absorbance at 405 nm). The
rate of the reaction is directly proportional to the en-
zyme activity. Statistical significance was determined
using ANOVA plus post hoc, p-value < 0.05.
The activity of beta-D-glucanase enzymes produced in
the two E. coli systems described above was compared
to the activity of beta glucanase purchased from
Megazyme (E-CELAN) and Sigma (49101). All pro-
teins were transferred into 10 mM PBS with pH 7.4
using Centricon Centrifugal Units with a 3 kDa cutoff.
The concentration of each enzyme was adjusted to
0.5 mg/mL and the activity was measured by using the
Azo-Barley Glucan Method (Megazyme, S-ABG100).
Each protein was incubated with Azo-Barley glucan
substrate following manufacturers instructions. The
dyed substrate was depolymerized by malt beta-
glucanase to fragments which are soluble in the pres-
ence of precipitant solution. Upon centrifugation of
the precipitant-treated reaction mixture, the absorb-
ance (at 590 nm) of the supernatant solution was dir-
ectly related to the activity of beta-glucanase in the
sample. Statistical significance was determined using
ANOVA plus post hoc, p-value < 0.05.
Carbonylation was measured as previously described
in [7]. In brief, 1 μg protein was bound to Nunc Maxi-
sorp Immunoplates (Sigma) and incubated overnight.
Carbonyl groups were derivatized using 2,4-Dinitrophe-
nylhydrazine (Sigma-Aldrich) and labeled using anti-DNP
primary antibody. After labeling with HRP-conjugated
secondary antibody, absorbance was read at 470 nm.
Statistical analyses of the data were conducted using
the GraphPad Prism Software. Since data followed
normal distribution, the differences between multiple
groups were compared using parametric one-way
ANOVA, followed by Tukey’s post-hoc test. For all tests
significance level was set at p < 0.05.
Results and discussion
In view of the fact that proteome functionality can be
improved by ribosomal mutations with decreased trans-
lation error rates, we tested whether this is the case for
individual proteins by expressing alpha-glucosidase and
beta-glucanase in rpsL141 background and measuring
their activity.
After purification, alpha-glucosidase and beta-glucanase
from both MG1655 and rpsL141 backgrounds, as well as
Megazyme and Sigma enzymes were assayed for their ac-
tivity. Their purity was checked using SDS-PAGE (Fig. 1.).
Alpha-glucosidase shows a prominent band at ≈ 65 kDa
and is approximately 86 % pure as estimated by ImageJ
software (Fig. 1b). Beta-glucanase displays a band at ≈
27 kDa, and a less prominent one at ≈ 65 kDa, which are
both reported sizes of beta-glucanase [9, 11]; since the ≈
65 kDa band varies in intensity between samples, we as-
sume the correct band is at ≈ 27 kDa and is ≈ 70 % pure
(Fig. 1b). Yields (here expressed as net amount obtained
from one extraction from 1 L of bacterial culture) for both
enzymes varied from 0.01 mg to 0.5 mg – this however
was affected by the method of extraction, as it varied
equally between both strains.
Fig. 1 a SDS-PAGE of purchased Megazyme and Sigma proteins. b SDS-PAGE of alpha-glucosidase and beta-glucanase from MG1655 and
rpsL141 background
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Alpha-glucosidase from rpsL141 background shows ≈
30 % increase in activity compared to both alpha-
glucosidase from MG1655 background and that pur-
chased from Megazyme. Compared to alpha-glucosidase
from Sigma, alpha-glucosidase from the rpsL141 back-
ground has roughly 80 % higher activity (Fig. 2). This sug-
gests that alpha-glucosidase activity can be increased
without changing the growth conditions as done in [4].
However, by combining these two approaches it may be
possible to obtain alpha-glucosidase with superior activity.
Beta-glucanase activity is also increased when expressed
in rpsL141 background compared to MG1655 and Sigma
enzyme, with activity increase of roughly 30 % compared
to these two enzymes. However, beta-glucanase from
Megazyme showed the highest activity (≈25 % higher than
beta-glucanase from rpsL141 background; Fig. 3).
Since we postulated that this heightened activity is a
direct consequence of lower oxidative damage, as a re-
sult of favorable folding environment due to lower trans-
lation error rates in rpsL141 mutant, we measured
carbonylation levels of all purified and purchased en-
zymes. Generally, the results demonstrate that height-
ened activity is paired with lower carbonylation levels
(Figs. 2 and 3). This supports our idea that enzyme spe-
cific activity can be increased by lowering its oxidative
damage, which was achieved by decreasing the transla-
tion error rate.
It should be noted that our purified enzymes and the
purchased products may not be directly comparable to
each other, as we are not familiar with the exact
purification process or any modifications made to pur-
chased enzymes that would render them highly active.
Furthermore, while our purified enzymes were assayed
immediately after purification and quantification, Sigma
and Megazyme enzymes were supplied in different
buffers and states and were subsequently placed in phos-
phate buffer (see Materials and Methods). Thus, we used
the purchased enzymes simply as a standard against
which we test our purified product, and to gauge its po-
tential as a commercial product.
Regardless of these limitations, we believe that this
assay supplies sufficient support to the hypothesis that
producing enzymes in an rpsL141-bearing system, and
thus reducing errors in protein synthesis, ultimately
leads to enzymes of superior functionality. De Marco
and colleagues [5] successfully increased the yield of
transgenic proteins from E. coli, while Thahn and col-
leagues [4] increased the enzyme recovery from inclu-
sion bodies. In contrast, we increased not the yield, but
the specific activity of purified proteins of interest likely
by lowering their susceptibility to oxidative damage,
thus presenting a new possibility for obtaining indus-
trial enzymes.
We anticipate that such proteins with improved activ-
ity can be obtained using a wide spectrum of purification
methods, as well as in different expression systems, and
that the purification process can easily be scaled up to
meet industrial needs. Since this is a very active field of
Fig. 2 Activity and carbonylation levels of alpha-glucosidase from
different backrounds. Figure represents biological and technical
replicates, statistical significance was determined using ANOVA
plus post hoc, p-value < 0.05. *** p < 0.001; ** p < 0.01
Fig. 3 Activity and carbonylation levels of beta-glucanase from
different backrounds. Figure represents biological and technical
replicates, statistical significance was determined using ANOVA
plus post hoc, p-value < 0.05. *** p < 0.001; ** p < 0.01. N.s. stands
for not significant
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research, and the need for more sustainable and efficient
processes is ever growing, small improvements to the ac-
tivity of single proteins can be significant for the produc-
tion process and the industrial or medical usage.
Conclusions
Our results demonstrate that reducing the translation
error rate, and thereby improving proteome quality, ul-
timately leads to superior functionality of single proteins.
Such proteins have a higher activity than those purified
from wild type E. coli, thus lowering the total amount
that would need to be purified and to carry out a given
volume of chemical reactions or to provide a given
therapeutic effect. We expect that this or a similar ex-
pression system bearing the rpsL141 mutation can be
used on a much larger scale, thus reducing the quota for
heterologous proteins by improving their functionality.
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